14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Celyad SA Stock and on which exchange is it traded?
The symbol for Celyad SA is CYAD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Celyad SA Stock?
Celyad SA holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Celyad SA Stock?
Celyad SA Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celyad SA Stock.

What's the current price of Celyad SA Stock?
As of the end of day on the Aug 17, 2023, the price of an Celyad SA (CYAD) share was $0.470.

What is the 52-week high and low for Celyad SA Stock?
The 52-week high for Celyad SA Stock is $3.07 and the 52-week low is $0.460.

What is the market capitalization of Celyad SA Stock?
As of the Aug 17, 2023, the market capitalization of Celyad SA is 14.238M.
Click to get the best stock tips daily for free!

About Celyad SA

Celyad SA Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT